Denis M. O'Donnell
Corporate Officer/Principal chez Seaside Capital Management LLC
Profil
Denis M.
O'Donnell has been a Director of Columbia Laboratories, Inc. since January 1999.
He is a Director of Novavax, Inc., ELXSI Corp.
and Molecular Diagnostics, Inc. and a Director and a Member of the Audit Committee for ELXSI, Inc. Dr. O'Donnell is Managing Director of Seaside Capital LLC.
From February 2004 to 2005, he was President and Chief Executive Officer of Molecular Diagnostics.
Dr. O'Donnell was Chairman of Novavax from May 2000 to 2005, Vice Chairman from June 1999 to May 2000, Senior Advisor from 1997 to 1998, President from 1995 to 1997 and Vice President from 1991 to 1995.
He was General Partner of Seaside Partners LP from 1997 to 2003.
Postes actifs de Denis M. O'Donnell
| Sociétés | Poste | Début |
|---|---|---|
Seaside Capital Management LLC
 Seaside Capital Management LLC Investment ManagersFinance Part of United Community Banks, Inc., Seaside Capital Management LLC is a company that provides investment advice. The company is based in Juno Beach, FL. | Corporate Officer/Principal | 01/01/1999 |
Anciens postes connus de Denis M. O'Donnell
| Sociétés | Poste | Fin |
|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Directeur/Membre du Conseil | 21/05/2009 |
| NOVAVAX, INC. | Directeur/Membre du Conseil | 20/03/2007 |
CytoCore, Inc.
 CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | President | 29/08/2005 |
| ELXSI CORPORATION | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
ELXSI Corp.
 ELXSI Corp. RestaurantsConsumer Services ELXSI Corp. engages in the operation of restaurants through its subsidiary Cues, Inc. It operates through the Equipment Manufacturer and Restaurant Operations segments. The Equipment Manufacturer segment engages in manufacturing and servicing of robotic video inspection and repair equipment and software for wastewater and drainage systems primarily for municipalities, service contractors and industrial users. The Restaurant Operations segment operates restaurant under the Bickford's brand name. The company was founded in September 1980 and is headquartered in Orlando, FL. | Consumer Services |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Seaside Capital Management LLC
Seaside Capital Management LLC Investment ManagersFinance Part of United Community Banks, Inc., Seaside Capital Management LLC is a company that provides investment advice. The company is based in Juno Beach, FL. | Finance |
